These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. Rex S; Schaelte G; Metzelder S; Flier S; de Waal EE; Autschbach R; Rossaint R; Buhre W Acta Anaesthesiol Scand; 2008 Jan; 52(1):65-72. PubMed ID: 17976224 [TBL] [Abstract][Full Text] [Related]
4. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Wang H; Gong M; Zhou B; Dai A Adv Ther; 2009 Apr; 26(4):462-8. PubMed ID: 19381522 [TBL] [Abstract][Full Text] [Related]
5. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction. Antoniou T; Prokakis C; Athanasopoulos G; Thanopoulos A; Rellia P; Zarkalis D; Kogerakis N; Koletsis EN; Bairaktaris A Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery. Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102 [TBL] [Abstract][Full Text] [Related]
9. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. Winterhalter M; Simon A; Fischer S; Rahe-Meyer N; Chamtzidou N; Hecker H; Zuk J; Piepenbrock S; Strüber M J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):406-13. PubMed ID: 18503929 [TBL] [Abstract][Full Text] [Related]
10. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Haraldsson s A; Kieler-Jensen N; Ricksten SE Anesth Analg; 2001 Dec; 93(6):1439-45, table of contents. PubMed ID: 11726420 [TBL] [Abstract][Full Text] [Related]
11. Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension. Laflamme M; Perrault LP; Carrier M; Elmi-Sarabi M; Fortier A; Denault AY J Cardiothorac Vasc Anesth; 2015 Feb; 29(1):38-45. PubMed ID: 25440627 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance. Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension. Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842 [TBL] [Abstract][Full Text] [Related]
14. Routine Intraoperative Inhaled Milrinone and Iloprost Reduces Inotrope Use in Patients Undergoing Cardiac Surgery: A Retrospective Cohort Pilot Study. Hu X; Li X; Boggett S; Yang Y; Chun-Ting W; Anstey J; Royse A; Royse C Anesth Analg; 2020 Aug; 131(2):527-536. PubMed ID: 32371741 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study. Kundra TS; Prabhakar V; Kaur P; Manjunatha N; Gandham R J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2123-2129. PubMed ID: 30098861 [TBL] [Abstract][Full Text] [Related]
16. Inhaled versus intravenous milrinone in mitral stenosis with pulmonary hypertension. Patel J; Patel K; Garg P; Patel S Asian Cardiovasc Thorac Ann; 2021 Mar; 29(3):170-178. PubMed ID: 33108898 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. Braun S; Schrötter H; Schmeisser A; Strasser RH Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747 [TBL] [Abstract][Full Text] [Related]
19. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Kramm T; Eberle B; Guth S; Mayer E Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948 [TBL] [Abstract][Full Text] [Related]
20. Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation. Sabato LA; Salerno DM; Moretz JD; Jennings DL Pharmacotherapy; 2017 Aug; 37(8):944-955. PubMed ID: 28543813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]